396 related articles for article (PubMed ID: 19138000)
1. The expression of human corneal MMP-2, MMP-9, proMMP-13 and TIMP-1 in bullous keratopathy and keratoconus.
Predović J; Balog T; Marotti T; Gabrić N; Bohac M; Romac I; Dekaris I
Coll Antropol; 2008 Oct; 32 Suppl 2():15-9. PubMed ID: 19138000
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V
Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814
[TBL] [Abstract][Full Text] [Related]
3. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
[TBL] [Abstract][Full Text] [Related]
5. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
Chen YS; Langhammer T; Westhofen M; Lorenzen J
Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea.
Heiligenhaus A; Li HF; Yang Y; Wasmuth S; Steuhl KP; Bauer D
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4079-85. PubMed ID: 16249483
[TBL] [Abstract][Full Text] [Related]
7. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid.
Niimi Y; Pawankar R; Kawana S
Int Arch Allergy Immunol; 2006; 139(2):104-13. PubMed ID: 16374020
[TBL] [Abstract][Full Text] [Related]
9. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
Ye HQ; Azar DT
Invest Ophthalmol Vis Sci; 1998 May; 39(6):913-21. PubMed ID: 9579471
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of matrix metalloproteinases and their tissue inhibitors as possible contributors to corneal droplet formation in climatic droplet keratopathy.
Holopainen JM; Serra HM; Sánchez MC; Sorsa T; Zalentein WN; Barcelona PF; Moilanen JA; Tervahartiala T; Tervo TM; Cafaro TA; Virtanen I; Urrets-Zavalia EA; Bhattacharya SK; Urrets-Zavalia JA
Acta Ophthalmol; 2011 Sep; 89(6):569-74. PubMed ID: 19900203
[TBL] [Abstract][Full Text] [Related]
11. [The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma].
Chen Y; Tian K; Geng N; Yang MZ; Zhang WP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan; 40(1):58-61. PubMed ID: 15774155
[TBL] [Abstract][Full Text] [Related]
12. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.
Sobrin L; Liu Z; Monroy DC; Solomon A; Selzer MG; Lokeshwar BL; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1703-9. PubMed ID: 10845589
[TBL] [Abstract][Full Text] [Related]
14. Complexes of gelatinases and tissue inhibitor of metalloproteinases in human seminal plasma.
Shimokawa K; Katayama M; Matsuda Y; Takahashi H; Hara I; Sato H
J Androl; 2003; 24(1):73-7. PubMed ID: 12514086
[TBL] [Abstract][Full Text] [Related]
15. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
Laplante A; Liu D; Demeule M; Annabi B; Murphy GF; Daloze P; Chen H; Béliveau R
Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Palei AC; Sandrim VC; Cavalli RC; Tanus-Santos JE
Clin Biochem; 2008 Jul; 41(10-11):875-80. PubMed ID: 18477480
[TBL] [Abstract][Full Text] [Related]
17. Elements of the nitric oxide pathway can degrade TIMP-1 and increase gelatinase activity.
Brown DJ; Lin B; Chwa M; Atilano SR; Kim DW; Kenney MC
Mol Vis; 2004 Apr; 10():281-8. PubMed ID: 15105792
[TBL] [Abstract][Full Text] [Related]
18. Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma.
Pennanen H; Kuittinen O; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Jan; 80(1):46-54. PubMed ID: 18028436
[TBL] [Abstract][Full Text] [Related]
19. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
[TBL] [Abstract][Full Text] [Related]
20. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
